These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22968906)

  • 1. Targeting hedgehog-GLI-2 pathway in osteosarcoma.
    Yang W; Liu X; Choy E; Mankin H; Hornicek FJ; Duan Z
    J Orthop Res; 2013 Mar; 31(3):502-9. PubMed ID: 22968906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
    Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
    Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
    Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
    Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GLI2 in the growth of human osteosarcoma.
    Nagao H; Ijiri K; Hirotsu M; Ishidou Y; Yamamoto T; Nagano S; Takizawa T; Nakashima K; Komiya S; Setoguchi T
    J Pathol; 2011 Jun; 224(2):169-79. PubMed ID: 21506130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between Hh and Wnt signaling promotes osteosarcoma progression.
    Xu Y; Yu P; Wang S; Jiang L; Chen F; Chen W
    Int J Clin Exp Pathol; 2019; 12(3):768-773. PubMed ID: 31933884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic relevance of PRAME in primary osteosarcoma.
    Tan P; Zou C; Yong B; Han J; Zhang L; Su Q; Yin J; Wang J; Huang G; Peng T; Shen J
    Biochem Biophys Res Commun; 2012 Mar; 419(4):801-8. PubMed ID: 22390931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines.
    Perez J; Bardin C; Rigal C; Anthony B; Rousseau R; Dutour A
    Anticancer Res; 2011 Sep; 31(9):2813-20. PubMed ID: 21868524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.
    Nathan SS; DiResta GR; Casas-Ganem JE; Hoang BH; Sowers R; Yang R; Huvos AG; Gorlick R; Healey JH
    Clin Cancer Res; 2005 Mar; 11(6):2389-97. PubMed ID: 15788690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen peroxide overload increases adriamycin-induced apoptosis of SaOS(2)FM, a manganese superoxide dismutase-overexpressing human osteosarcoma cell line.
    Wang Y; Kuroda M; Gao XS; Asaumi J; Shibuya K; Kawasaki S; Akaki S; St Clair D; Hiraki Y; Kanazawa S
    Int J Oncol; 2005 May; 26(5):1291-300. PubMed ID: 15809720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
    Luk F; Yu Y; Walsh WR; Yang JL
    Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma.
    Rainusso N; Brawley VS; Ghazi A; Hicks MJ; Gottschalk S; Rosen JM; Ahmed N
    Cancer Gene Ther; 2012 Mar; 19(3):212-7. PubMed ID: 22173710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin.
    Chakkalakal DA; Mollner TJ; Bogard MR; Fritz ED; Novak JR; McGuire MH
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):89-98. PubMed ID: 10738905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
    Benjamin R; Helman L; Meyers P; Reaman G
    Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
    Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
    Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
    Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
    Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
    Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression.
    Lézot F; Corre I; Morice S; Rédini F; Verrecchia F
    Cells; 2020 Feb; 9(3):. PubMed ID: 32110934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.